The FMR1 premutation as a cause of premature ovarian failure in Brazilian women

Genetics and Molecular Biology

Volumn 29, Issue 3, 2006, Pages 423-428

  Costa, Silvia S ^a   da Fonseca, Angela M ^a   Bagnoli, Vicente R ^a   Vianna Morgante, Angela M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

FMR1 premutation; Fragile X syndrome; Menopause; Premature ovarian failure

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

ADULT; ALLELE; ARTICLE; BLOOD CELL; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; FRAGILE X SYNDROME; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; MENOPAUSE; MUTATIONAL ANALYSIS; PREMATURE OVARIAN FAILURE; PROBABILITY; RISK ASSESSMENT; X CHROMOSOME INACTIVATION;

EID: 33748659232     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572006000300002     Document Type: Article

References (41)

1. Aittomaki K, Herva R, Stenman U-H, Juntunen K, Ylostalo P, Hovatta O and de la Chapelle A (1996) Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocr Metab 81:3722-3726.
2. Allingham-Hawkins DJ, Babul-HirJi R, Chitayat D, Holden JJA, Yang KT, Lee C, Hudson R, Gorwill H, Sarah L, Nolin SL, Glicksman A, Jenkins EC, Brown WT, Howard-Peebles PN, Becchi C, Cummings E, Fallon L, Seitz S, Black SH, Vianna-Morgante AM, Costa SS, Otto PA, Mingroni-Netto RC, Murray A, Webb J, MacSwinney F, Dennis N, Jacobs PA, Syrrou M, Georgiou I, Patsalis PC, Uzielli MLG, Guarducci S, Lapi E, Cecconi A, Ricci U, Ricotti G, Biondi C, Scarselli B and Vieri F (1999) Fragile X premutation is a significant risk factor for premature ovarian failure - The International Collaborative POF in Fragile X Study - Preliminary data. Am J Med Genet 83:322-325.
3. Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, Milgrom E, Kuttenn F and Misrahi M (1998) A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest 102:1352-1359.
4. Bione S, Sala C, Manzini C, Arrigo G, Zuffardi O, Banfi S, Borsani G, Jonveaux P, Philippe C, Zuccotti M, Ballabio A and Toniolo D (1998) A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: Evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet 62:533-541.
5. Braat DD, Smits AP and Thomas CM (1999) Menstrual disorders and endocrine profiles in fragile X carriers prior to 40 years of age: A pilot study Am J Med Genet 83:327-328.
6. Chiurazzi P, Genuardi M, Kozak L, Giovannucci-Uzielli ML, Bussani C, Dagna-Bricarelli F, Grasso M, Perroni L, Sebastio G, Sperandeo MP, Oostra BA and Neri G (1996) Fragile X founder chromosome in Italy: A few initial events and possible explanation for their heterogeneity. Am J Med Genet 64:209-215.
7. Conway GS, Hettiarachchi S, Murray A and Jacobs PA (1995) Fragile X premutations in familial premature ovarian failure. Lancet 346:309-310.
8. Coulam CB, Adamson SC and Annegers JF (1986) Incidence of premature ovarian failure. Obstet Gynecol 67:604-606.
9. Crawford DC, Acuna JM and Sherman SL (2001) FMR1 and the fragile X syndrome: Human genome epidemiology review. Genet Med 3:359-371.
10. Cronister A, Schreiner R, Wittenberger M, Amiri K, Harris K and Hagerman RJ (1991) Heterozygous fragile X female: Historical, physical, cognitive, and cytogenetic features. Am J Med Genet 38:269-274.
11. Day JW and Ranum LPW (2005) RNA pathogenesis of the myotonic dystrophies. Neurom Disord 15:5-16.
12. Eichler EE, Holden JJ, Popovich BW, Reiss AL, Snow K, Thibodeau SN, Richards CS, Ward PA and Nelson DL (1994) Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet 8:88-94.
13. Fogli A, Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF, Zeesman S, Kaneski CR, Schiffmann R and Boespflug-Tanguy O (2003) Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet 72:1544-1550.
14. Fu YH, Kuhl DPA, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJMH, Holden JJA, Fenwick Jr RG, Warren ST, Ostra BA, Nelson DL and Caskey CT (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67:1047-1058.
15. Hagerman PJ and Hagerman RJ (2004) The fragile-X premutation: A maturing perspective. Am J Hum Genet 74:805-816.
16. Harris SE, Chand AL, Winship IM, Gersak K, Aittomaki K and Shelling AN (2002) Identification of novel mutations in FOXL2 associated with premature ovarian failure. Molec Hum Reprod 8:729-733, 2002.
17. Hundscheid RDL, Braat DDM, Kiemeney LALM, Oostra BA, Smits APT and Thomas CMG (2001) Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum Reprod 16:457-462.
18. Hundscheid RDL, Sistermans EA, Thomas CMG, Braat DDM, Straatman H, Kiemeney LALM, Oostra BA and Smits APT (2000) Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations. Am J Hum Genet 66:413-418.
19. Kenneson A, Cramer DW and Warren ST (1997) Fragile X premutations are not a major cause of early menopause. Am J Hum Genet 61:1362-1369.
20. Macpherson JN, Bullman H, Yuings SA and Jacobs PA (1994) Insert size and flanking haplotype in fragile X and normal populations: Possible multiple origins for the fragile X mutation Hum Mol Genet 3:399-405.
21. Marozzi A, Vegetti W, Manfredini E, Tibiletti G, Testa G, Crosignani PG, Ginelli E, Meneveri R and Dalprà L (2000) Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod 15:197-202.
22. Mingroni-Netto RC, Angeli CB, Auricchio MT, Leal-Mesquita ER, Ribeiro-Dos-Santos AK, Ferrari I, Hutz MH, Salzano FM, Hill K, Hurtado AM and Vianna-Morgante AM (2002) Distribution of CGG repeats and FRAXACI/ DXS548 alleles in South American populations. Am J Med Genet 111:243-52.
23. Mingroni-Netto RC, Costa SS, Angeli CB and Vianna-Morgante AM (1999) DXS548/FRAXAC1 haplotypes in fragile X chromosomes in the Brazilian population. Am J Med Genet 84:204-207.
24. Mingroni-Netto RC, Fernandes JG and Vianna-Morgante AM (1994) Relationship of expansion of CGG repeats and X-inactivation with expression of fra(X)(q27.3) in heterozygotes Am J Med Genet 5:443-446.
25. Murray A, Ennis S and Morton N (2000) No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers. Am J Hum Genet 67:253-254.
26. Murray A, Macpherson JN, Pound MC, Sharrock A, Youings SA, Dennis NR, Mckechnie N, Iinehan P, Morton NE and Jacobs PA (1997) The role of size, sequence and haplotype in the stability of FRAXA and FRAXE alleles during transmission. Hum Mol Genet 6:173-84.
27. Murray A, Webb J, Grimley S, Conway GS and Jacobs PA (1998) Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 35:637-640.
28. Murray A, Webb J, MacSwiney F, Shipley EL, Morton NE and Conway GS (1999) Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod 14:1217-1218.
29. Nolin SL, Brown WT, Glicksman A, Houck Jr GE, Gargano AD, Sullivan A, Biancalana V, Brondum-Nielsen K, Hjalgrim H, Holinski-Feder E, Kooy F, Longshore J, Mandel JL, Matthijs G, Rosseau F, Steinbach P, Vaisanen ML, Von Koskull H and Sherman SL (2003) Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 72:454-464.
30. Oberlé I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boué J, Bertheas MF and Mandel JL (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102.
31. Pieretti M, Zhang F, Fu YH, Warren ST, Oostra BA, Caskey CT and Nelson DL (1991) Absence of expression of the FMR1 gene in fragile X syndrome. Cell 66:817-822.
32. Richards RI, Holman K, Kozman H, Kremer E, Lynch M, Pritchard M, Yu S, Mulley J and Sutherland GR (1991) Fragile X syndrome: Genetic localisation by linkage mapping of two microsatellite repeats FRAXAC1 and FRAXAC2 which immediately flank the fragile site. J Med Genet 28:818-823.
33. Riggins GJ, Sherman SL, Oostra BA, Sutcliffe JS, Feitell D, Nelson DL, Van Oost BA, Smits APT, Ramos FJ, Pfendner E, Kuhl DPA, Caskey CT and Warren ST (1992) Characterization of a highly polymorphic dinucleotide repeat 150 kb proximal to the fragile X site. Am J Med Genet, 43:237-243.
34. Schwartz CE, Dean J, Howard-Peebles PN, Bugge M, Mikkelsen M, Tommerup N, Hull C, Hagerman R, Holden JJA and Stevenson RE (1994) Obstetrical and gynecological complications in fragile X carriers: A multicenter study. Am J Med Genet 51:400-402.
35. Sherman SL (2000) Premature ovarian failure among fragile X premutation carriers: Parent-of-origin effect? Am J Hum Genet 67:11-13.
36. Sullivan AK, Markus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M and Sherman SL (2005) Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 20:402-412.
37. Tassone F, Hagerman RJ, Chamberlain WD and Hagerman PJ (2000) Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet 97:195-203.
38. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, Van Ommen G-JB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA and Warren ST (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
39. Vianna-Morgante AM and Costa SS (2000) Premature ovarian failure is associated with maternally and paternally inherited premutations in Brazilian families with fragile X. Am J Hum Genet 67:254-255.
40. Vianna-Morgante AM, Costa SS, Pares AS and Verreschi ITN (1996) FRAXA premutation associated with premature ovarian failure. Am J Med Genet 64-373-375.
41. Vianna-Morgante AM, Costa SS, Pavanello RCM, Otto PA and Mingroni-Netto RC (1999) Premature ovarian failure (POF) in Brazilian fragile X carriers. Genet Mol Biol, 22:471-474.